NTLA and CRSPN Related Headlines

Go Back

Oct 27, 2025 07:59AM Intellia stock tumbles after pausing gene therapy trials on safety concerns

NTLA and CRSPN Related Press Releases

Go Back

NTLA and CRSPN Related SEC Filings

Go Back